Health
Vaccine experts meeting over clot report – The Islander
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians. The Therapeutic……
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians.
The Therapeutic Goods Administration and Australian Technical Advisory Group on Immunisation met on Saturday morning and Acting Chief Medical Officer Michael Kidd said no changes to the AstraZeneca rollout were recommended.
He said it was likely, given similarities with rare overseas cases, that the man’s clotting disorder was related to him receiving the…
-
General15 hours agoFerries and celebrities as pollies dash to win the west
-
Noosa News19 hours agoCSIRO, winemakers pair to breed mildew, climate-resistant grapevines
-
Business20 hours ago3 ASX 200 stocks I’d buy and hold for the next 10 years
-
Noosa News16 hours agoChild killer Rick Thorburn who murdered Tiahleigh Palmer found dead in jail cell